Minority patients were more likely to undergo the four life-sustaining procedures – gastrostomy (feeding tube insertion), tracheostomy, mechanical ventilation and hermicraniectomy (to relieve pressure on the brain) – after stroke than white patients, according to a research letter published online by JAMA Neurology. But the odds of undergoing intravenous thrombolysis and carotid revascularization – those procedures with curative intent – were lower for minority patients, according to the results. The authors note clinical factors, such as stroke severity, stroke location and time to presentation, not captured in the data could partially explain their results. Another stroke-related study published in JAMA Internal Medicine found that acute stroke treatment at a primary stroke center is associated with a seven-day and 30-day survival benefit compared to a non-certified center. The study authors suggest that admission to a PSC was associated with a 1.8% lower seven-day and 30-day death rate, although traveling at least 90 minutes to a PSC appears to offset any benefit of care there. 

Related News Articles

Headline
A Health-ISAC (Information Sharing and Analysis Center) bulletin released Oct. 1 warns of a recently released LockBit 5.0 ransomware variant that poses a…
Headline
AHA Trustee Services will host a webinar Nov. 5 from 3-4:30 p.m. ET on the role of board leaders in creating productive and engaging board meetings and…
Headline
The federal government shutdown will continue as the Senate Oct. 3 failed to adopt a government funding deal. The latest attempt to pass the House-passed…
Perspective
Public
“Trust but verify” is a phrase often associated with President Reagan and the need to ensure that treaties enacted with the Soviet Union were being upheld.…
Headline
A JAMA study published yesterday analyzed the health characteristics of individuals projected to lose Medicaid coverage due to work requirements included in…
Headline
The Department of Health and Human Services announced Sept. 30 that it is doubling its funding for childhood cancer research from $50 million to $100 million…